Thank you for the free lecture in biotech 101. I don't know how you interpreted my post to think I suggest RXI go it alone into PIII. My last comment was for the company to partner to get RX-109 pushed through to commercialization. If RXI were to suggest going it alone I would find a good price to sell and get out. Been there, done that.